Evidence map›Paper›PMID 19615955›Full record

ReviewMolecular oncology2009

Ras/MAPK signaling from endomembranes.

Nicole Fehrenbacher, Dafna Bar-Sagi, Mark Philips

Open access · bronzeAbstract readReview
In one paragraph

Review in Molecular oncology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 87 papers.

0numbers the graph read from it
0cells of the map it votes in
87citing papers in PubMed
6.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

87 citing papers in PubMed, 152 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Targeting PI3K/AKT/mTOR and MAPK Signaling Pathways in Gastric Cancer.International journal of molecular sciences · 2024
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Genomic mutation characteristics and prognosis of biliary tract cancer.American journal of translational research · 2022
    Article
  16. Article
  17. Review
  18. Endosomes as Signaling Platforms for IL-6 Family Cytokine Receptors.Frontiers in cell and developmental biology · 2021
    Review
  19. Review
  20. Review

27 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Nicole FehrenbacherDepartment of Cell Biology, NYU School of Medicine, New York, NY 10016, USA.
Dafna Bar-Sagi
Mark Philips
New York University · US

Funding

MEDICAL SCIENTIST TRAININGT32GM007308 · NIGMS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI PHILIPS, MARK REID · 1985 to 2019
$23.2M
MECHANISMS OF SIGNAL TRANSDUCTION BY RAS PROTEINSR37CA055360 · NCI · STATE UNIVERSITY NEW YORK STONY BROOK · PI BAR-SAGI, DAFNA · 2001 to 2008
$3.4M
Regulation of K-Ras by a Farnesyl-electrostatic SwitchR01CA116034 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI PHILIPS, MARK REID · 2005 to 2017
$3.4M
Membrane Targeting of GTPasesR01GM055279 · NIGMS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI PHILIPS, MARK REID · 1997 to 2010
$3.2M
Isoprenylcysteine Carboxyl Methyltransferase (ICMT) as a Target in NRAS Driven Melanoma - Resubmission - 1R01CA163489 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI PHILIPS, MARK REID · 2012 to 2020
$2.8M
MECHANISMS OF SIGNAL TRANSDUCTION BY RAS PROTEINSR01CA055360 · NCI · STATE UNIVERSITY NEW YORK STONY BROOK · PI BAR-SAGI, DAFNA · 1991 to 2015
$2.6M
Structure/Function Analysis of IcmtR01CA118495 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI PHILIPS, MARK REID · 2006 to 2010
$1.5M
Mechanisms of Signal Transduction by Ras ProteinsR56CA055360 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI BAR-SAGI, DAFNA · 2009 to 2009
$484k
NCI NIH HHS CA055360NCI NIH HHS CA116034NCI NIH HHS CA118495NCI NIH HHS R01 CA055360NCI NIH HHS R01 CA116034NCI NIH HHS R01 CA118495NCI NIH HHS R01 CA163489NCI NIH HHS R37 CA055360NCI NIH HHS R56 CA055360NIGMS NIH HHS GM055279NIGMS NIH HHS R01 GM055279NIGMS NIH HHS T32 GM007308
6 · The paper itself

Abstract

Signal transduction along the Ras/MAPK pathway has been generally thought to take place at the plasma membrane. It is now evident that the plasma membrane is not the only platform capable of Ras/MAPK signal induction. Fusion of Ras with green fluorescent protein and the development of genetically encoded fluorescent probes for Ras activation have revealed signaling events on a variety of intracellular membranes including endosomes, the Golgi apparatus and the endoplasmic reticulum. Thus, the Ras/MAPK pathway is spatially compartmentalized within cells and this may afford greater complexity of signal output.

Indexed as

Signal TransductionEndosomesFemaleGolgi ApparatusHumansIntracellular MembranesMaleMitogen-Activated Protein Kinase KinasesModels, Biologicalras ProteinsMitogen-Activated Protein Kinase Kinasesras Proteins

Identifiers

PMID19615955
PMCPMC3003591
OpenAlexW2146889169

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.